1	Iniciar	iniciar	VMN0000	-	-	0-7	34(1)_ANS_clinical_caseMIR	SENT1	-	-
2	tratamiento	tratamiento	NCMS000	C1273870#C0087111	procedimiento#régimen/tratamiento	8-19	34(1)_ANS_clinical_caseMIR	SENT1	-	-
3	con	con	SPS00	C0332287	atributo	20-23	34(1)_ANS_clinical_caseMIR	SENT1	-	-
4	prednisona	prednisona	NCFS000	C0032952	sustancia	24-34	34(1)_ANS_clinical_caseMIR	SENT1	B-Grp_Medicamento	-
5	60mg	60mg		-	-	35-39	34(1)_ANS_clinical_caseMIR	SENT1	-	-
6	al	al	SP+DA	-	-	40-42	34(1)_ANS_clinical_caseMIR	SENT1	-	-
7	día	día	NCMS000	C0439228#C0332169	calificador	43-46	34(1)_ANS_clinical_caseMIR	SENT1	-	-
8	y	y	CC	C1706368	calificador	47-48	34(1)_ANS_clinical_caseMIR	SENT1	-	-
9	aspirina	aspirina	NCFS000	C0004057	sustancia	49-57	34(1)_ANS_clinical_caseMIR	SENT1	B-Grp_Medicamento	-
10	100	100	Z	-	-	58-61	34(1)_ANS_clinical_caseMIR	SENT1	-	-
11	mg	mg	NCMN000	-	-	62-64	34(1)_ANS_clinical_caseMIR	SENT1	-	-
12	al	al	SP+DA	-	-	65-67	34(1)_ANS_clinical_caseMIR	SENT1	-	-
13	día	día	NCMS000	C0439228#C0332169	calificador	68-71	34(1)_ANS_clinical_caseMIR	SENT1	-	-
14	.	.	Fp	-	-	72-73	34(1)_ANS_clinical_caseMIR	SENT1	-	-

